Sunday, September 5, 2010
Bio Synthesis offer custom conjugation of liposome by covalently attached peptides, oligonucleotides, antibodies to the surface of liposomes or lipid emulsions. Lipsome bioconjugations are used as delivery devices to encapsulate cosmetics, drugs, fluorescent detection reagents and as vehicles to transport nucleic acids peptides, and proteins to cellular site in vivo. Antibody can be attached to liposomal surfaces and used to create large antigen- specific complexes for generation of specific antibodies or as vaccine carrier to elicit protective immunity.
End-Products of Liposome Technology
The various end products are Phosphatidyl Choline (PC), Lyso-phosphatidylcholine, Phosphatidyl Glycerol (PG), Phosphatidic acid, Phosphatidyl Inositol (PI), Phosphatidyl Ethanolamine (PE), Phosphatidyl Serine (PS), PEG-phospholipids, Polyglycerine phospholipids and other derivatives, Diacylglycerol-PEG, Cholesterol-PEG derivatives, Fluorescened phospholipids, Myristic acid, Palmitic acid, Stearic acid.
Use of End-Products of Liposome Technology
The end-products of liposome technology are widely used in retail markets, for the diagnosis of disease, as therapeutic agents, as vaccines, and assay designed to detect and quantify certain analytes.